Search by Drug Name or NDC
NDC 70069-0727-25 CALCIUM GLUCONATE 98 mg/mL Details
CALCIUM GLUCONATE 98 mg/mL
CALCIUM GLUCONATE is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Somerset Therapeutics, LLC. The primary component is CALCIUM GLUCONATE MONOHYDRATE.
Product Information
| NDC | 70069-0727 |
|---|---|
| Product ID | 70069-727_1f5d8743-2de0-4cab-9a81-612ab186b91f |
| Associated GPIs | |
| GCN Sequence Number | 001356 |
| GCN Sequence Number Description | calcium gluconate VIAL 100 MG/ML INTRAVEN |
| HIC3 | C1F |
| HIC3 Description | CALCIUM REPLACEMENT |
| GCN | 03820 |
| HICL Sequence Number | 000585 |
| HICL Sequence Number Description | CALCIUM GLUCONATE |
| Brand/Generic | Generic |
| Proprietary Name | CALCIUM GLUCONATE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | CALCIUM GLUCONATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 98 |
| Active Ingredient Units | mg/mL |
| Substance Name | CALCIUM GLUCONATE MONOHYDRATE |
| Labeler Name | Somerset Therapeutics, LLC |
| Pharmaceutical Class | Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA217689 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70069-0727-25 (70069072725)
| NDC Package Code | 70069-727-25 |
|---|---|
| Billing NDC | 70069072725 |
| Package | 25 VIAL, PLASTIC in 1 CARTON (70069-727-25) / 50 mL in 1 VIAL, PLASTIC |
| Marketing Start Date | 2023-10-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |